Navigation Links
Genta Completes Appeal of FDA Decision for Genasense(R) in CLL
Date:10/25/2007

can Society of Hematology (ASH) in December 2007.

- The Genasense study is the only randomized controlled trial ever

conducted in this population.

- The number, type, and severity of adverse reactions encountered with

Genasense were comparable to other leukemia drugs, which are readily

managed by specialists.

Genasense in CLL

In the pivotal Phase 3 trial, patients with relapsed or refractory CLL were randomly assigned to receive fludarabine plus cyclophosphamide (Flu/Cy) chemotherapy with or without Genasense. This trial - the first randomized study ever conducted in this population - achieved its primary endpoint, which was a statistically significant increase in the proportion of patients who achieved a complete or nodular partial response (CR/nPR) (17% vs. 7%; P=0.025). In addition, the duration of CR/nPR was significantly longer for patients treated with Genasense (median = not reached but exceeding 36 months in the Genasense group vs. 22 months for patients treated with chemotherapy alone).

Prior to randomization on this trial, patients were prospectively stratified according to criteria that reflected their responsiveness to prior chemotherapy. The CR/nPR response to Flu/Cy alone was both equally poor (6-7%) and numerically inferior in all stratification groups. Clear trends, evident across all strata, suggested that the best response to Genasense occurred in patients who had received less extensive therapy. In addition to achieving the prospectively defined, intent-to-treat primary endpoint, patients in the Genasense group who were protocol-defined as "non-refractory" to fludarabine (comprising more than 40% of the total population) achieved:

- A four-fold increase in CR/nPR (25% [13/51] vs. 6% [3/50]; P = 0.016)

- Increased time-to-progression (median = 12 months. vs. 10 months;

P = N.S.)

- Increased overall survival (median not reached but exceeding 39 months.

vs. 33
'/>"/>

SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Sonic Foundry completes $11.25M stock offer
2. Orion Energy completes $5M capital round
3. RedPrairie completes MARC acquisition
4. Metavante completes purchase of check processing firm
5. GE completes $1.2 billion acquisition
6. M & Is Metavante completes Brasfield Corp. acquisition
7. Metavante completes GHR Systems acquisition
8. Metavante completes TREEV acquisition
9. Johnson Controls completes sale of French unit
10. OpGen completes $5 million investment round
11. UW Hospital completes deployment of error-reducing technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/16/2014)... The “Fluid Management & Visualization Systems Market”, ... with an analysis and forecast of value by ... warming and waste management. Along with this, the ... by applications and regions are also discussed in ... $19,285.5 million in 2013 and is expected to ...
(Date:11/15/2014)... The International Society for ... the society’s Governing Board has grown with the ... scientific officer and Dr. Charles Simonton, divisional vice ... Mr. Rowe and Dr. Simonton are both ... , Dr. Nabil Dib, ISCTR President stated, ...
(Date:11/15/2014)... November 14, 2014 New photonics entrepreneurs ... Startup Challenge 2015 , an opportunity to pitch their ... experts and venture capitalists. The annual competition is held ... Center in San Francisco, running 7-12 February and hosted ... photonics . , Cash prizes, including $10,000 for first ...
(Date:11/15/2014)... -- F. David Rollo , MD, Ph.D., FACC, FACNP ... Professional in the field of Medicine as a result ... Cell Point is a privately held biotechnology ... , Houston and ... ethylenedicysteine drug conjugate technology ("EC Technology"), In-Situ Hydrogel ("In ...
Breaking Biology Technology:Fluid Visualization Systems Market poised to reach $25,908.4 Million by 2018 - New Research Report by MarketsandMarkets 2Fluid Visualization Systems Market poised to reach $25,908.4 Million by 2018 - New Research Report by MarketsandMarkets 3Fluid Visualization Systems Market poised to reach $25,908.4 Million by 2018 - New Research Report by MarketsandMarkets 4International Society for Cardiovascular Translational Research Governing Board Adds Medical Industry Leaders 2New Photonics Entrepreneurs Need to Apply Now for SPIE Startup Challenge 2015 2New Photonics Entrepreneurs Need to Apply Now for SPIE Startup Challenge 2015 3F. David Rollo, MD, Ph.D., FACC, FACNP is recognized by Continental Who's Who as a Pinnacle Professional 2
... better predict general patterns of evolution, a University of ... surprising things about gene mutations that might one day ... disease. UH evolutionary biologist Timothy Cooper and ... "Negative Epistasis Between Beneficial Mutations in an Evolving Bacterial ...
... WESTBROOK, Maine, June 2, 2011 IDEXX Laboratories, Inc. (NASDAQ: ... in the William Blair & Company 31st Annual Growth Stock ... a presentation on the Company on Tuesday, June 14, 2011 ... Chicago, Illinois. Individuals can access the live audio webcast of ...
... Morphotek®, Inc., a subsidiary of Eisai Inc., announced today ... of MORAb-004 for the treatment of metastatic melanoma. The ... that specifically binds to endosialin/tumor endothelial marker-1 (TEM-1), as ... activity at two dosages. The trial is ...
Cached Biology Technology:Work by UH evolutionary biologist may one day help with chronic diseases 2Morphotek®, Inc. Announces Initiation of MORAb-004 Phase II Study in Melanoma 2Morphotek®, Inc. Announces Initiation of MORAb-004 Phase II Study in Melanoma 3
(Date:11/3/2014)... Researchers from Australia report that low birth weight and ... (OA)-related hip replacements in adulthood. Findings published in the ... & Research , indicate that low birth weight and ... arthroplasty due to OA as adults. , According ... of 25 are diagnosed with clinical OA. Symptoms of ...
(Date:11/2/2014)... was fascinating to put a flashlight up to our ... Washington University in St. Louis engineers are using a ... to improve imaging of cancerous tissues and to develop ... K. Beare Distinguished Professor of Biomedical Engineering at the ... novel time-reversal technology that allows researchers to better focus ...
(Date:10/31/2014)... Brazil was the world,s largest producer of cocoa. Chocolate ... 800, 000 ha region of rainforest in the state ... trees. Whereas the surrounding rainforest was a biodiversity hotspot, ... handful of seeds introduced in the mid 1700s, had ... scientist Gonçalo Pereira, "This scenario created a very romantic, ...
Breaking Biology News(10 mins):Preterm, low birth-weight babies may need new hips in adulthood 2Improving imaging of cancerous tissues by reversing time 2Scientists seek cure for devastating witches' broom disease of the chocolate tree 2Scientists seek cure for devastating witches' broom disease of the chocolate tree 3
... Product Development, teaming with,Ball Aerospace & Technologies Corp., ... a new thermal insulation. NASA has awarded,the team ... to develop and,commercialize this advanced thermal insulation., ... and exploration missions would preserve rocket fuels such ...
... Dr. Marie-Jolle Rochet, a research scientist at IFREMER (The ... been awarded the prestigious Pew Fellowship in Marine Conservation ... least harmful to the delicately balanced marine ecosystem. She ... encourage widespread use of that technique, and to further ...
... the Integrated Ocean Drilling Programs Nankai Trough Seismogenic ... Kii Peninsula today. The expedition science party, 26 ... 19, 2007, aboard the drilling vessel Chikyu, to ... of the Nankai Trough fault zone. The expedition ...
Cached Biology News:Colorado Engineering Firms Win NASA Grant to Develop Innovative Insulation for Next Generation Spacecraft - Super-Insulation May Allow Future Energy Efficient Appliances 22008 Pew Fellowship in Marine Conservation awarded to Dr. Marie-Joëlle Rochet from IFREMER 22008 Pew Fellowship in Marine Conservation awarded to Dr. Marie-Joëlle Rochet from IFREMER 32008 Pew Fellowship in Marine Conservation awarded to Dr. Marie-Joëlle Rochet from IFREMER 4Scientists obtain core samples from subsea fault system off Japan 2